Link to an amendment published at 86 FR 33885, June 28, 2021.

1. (a) Each person registered or authorized (by § 1301.22 of this chapter) to maintain and/or detoxify controlled substance users in a narcotic treatment program shall maintain records with the following information for each narcotic controlled substance:

   1. (1) Name of substance;
   2. (2) Strength of substance;
   3. (3) Dosage form;
   4. (4) Date dispensed;
   5. (5) Adequate identification of patient (consumer);
   6. (6) Amount consumed;
   7. (7) Amount and dosage form taken home by patient; and
   8. (8) Dispenser's initials.
2. (b) The records required by paragraph (a) of this section will be maintained in a dispensing log at the narcotic treatment program site and will be maintained in compliance with § 1304.22 without reference to § 1304.03.
3. (c) All sites which compound a bulk narcotic solution from bulk narcotic powder to liquid for on-site use must keep a separate batch record of the compounding.
4. (d) Records of identity, diagnosis, prognosis, or treatment of any patients which are maintained in connection with the performance of a narcotic treatment program shall be confidential, except that such records may be disclosed for purposes and under the circumstances authorized by part 310 and 42 CFR part 2.

[39 FR 37985, Oct. 25, 1974. Redesignated and amended at 62 FR 13961, Mar. 24, 1997]